Toggle navigation
Pipeline
Pipeline
Pipeline Chart
uPAR-targeted radiopharmaceuticals
MNPR-101
Overview
Development Strategy
SNMMI Poster June 2024
EANM Presentation October 2024
Collaborations
Overview
Current Collaborations
Publications
MNPR-101
ALXN1840
Investors
Investors
Overview
Annual Meeting
News / Events
Press Releases
IR Calendar
In the News
Email Alerts
Company Information
Profile
Presentations
Our Team
FAQ
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Board of Directors
Board Committees
Governance Documents
Our Team
Our Team
Careers
Careers
Contact Us
Contact Us
Home
Investors
News / Events
In the News
Investors
Investors
Overview
Annual Meeting
News / Events
Press Releases
IR Calendar
In the News
Email Alerts
Company Info
Profile
Presentations
Our Team
FAQ
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Board of Directors
Board Committees
Governance Documents
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
News / Events
Press Releases
IR Calendar
In the News
Email Alerts
In the News
Scholars Join Forces on Anti-Cancer Drug
Sep 21, 2022
Monopar Therapeutics readies two key clinical trials in fourth quarter
Oct 6, 2020
Monopar Therapeutics Rings the Opening Bell
Mar 11, 2020
Best first-day IPO
Feb 12, 2020
Double success for Chandler Robinson
Feb 4, 2020
Article Published by Northwestern University on January 28, 2020
Jan 28, 2020
Scroll to top
